Therefore, we believe the primary action of tumor-derived IL-17A in tumor-bearing mice is to induce a rapid expansion of myeloid cells, including neutrophils and MDSCs, via the production of STAT3-activating cytokines including IL-6, G-CSF, and GM-CSF by tumor cells. Here, IL17A is linked to neoplasm.